ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Japan to launch initiative for AI-based drug discovery

TOKYO -- Japanese drugmakers are joining forces with information technology companies and research institutions to create a government-backed consortium aimed at using artificial intelligence to discover new drugs more efficiently.

Among the roughly 50 corporations joining the initiative, due to kick off soon, are Takeda PharmaceuticalFujifilm HoldingsShionogi & Co.Fujitsu and NEC. The government-affiliated Riken institute and Kyoto University will also take part, as will IT companies and drugmakers from abroad.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more